Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Teal RW"'
Autor:
Ray EM; Department of Medicine, Division of Oncology, University of North Carolina, Chapel Hill, North Carolina, United States of America.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, United States of America., Teal RW; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, United States of America.; Connected Health Applications and Interventions Core, University of North Carolina, Chapel Hill, North Carolina, United States of America., Carda-Auten J; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, United States of America.; Connected Health Applications and Interventions Core, University of North Carolina, Chapel Hill, North Carolina, United States of America., Coffman E; Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, United States of America., Sanoff HK; Department of Medicine, Division of Oncology, University of North Carolina, Chapel Hill, North Carolina, United States of America.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, United States of America.
Publikováno v:
PloS one [PLoS One] 2023 Jun 22; Vol. 18 (6), pp. e0287338. Date of Electronic Publication: 2023 Jun 22 (Print Publication: 2023).
Autor:
Dimond EP; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE dimonde@mail.nih.gov., Zon RT; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Weiner BJ; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., St Germain D; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Denicoff AM; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Dempsey K; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Carrigan AC; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Teal RW; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Good MJ; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., McCaskill-Stevens W; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Grubbs SS; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Dimond EP; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE dimonde@mail.nih.gov., Zon RT; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Weiner BJ; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., St Germain D; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Denicoff AM; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Dempsey K; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Carrigan AC; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Teal RW; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Good MJ; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., McCaskill-Stevens W; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Grubbs SS; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE.
Publikováno v:
Journal of oncology practice [J Oncol Pract] 2016 Jan; Vol. 12 (1), pp. 63-4, e23-35. Date of Electronic Publication: 2015 Dec 01.